Skip to main content

Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) Supported by Emerging Digital Technologies.

Publication ,  Journal Article
Sabbagh, MN; Boada, M; Borson, S; Chilukuri, M; Doraiswamy, PM; Dubois, B; Ingram, J; Iwata, A; Porsteinsson, AP; Possin, KL; Rabinovici, GD ...
Published in: J Prev Alzheimers Dis
2020

Disease-modifying pharmacotherapies for Alzheimer's Disease (AD) are currently in late-stage clinical development; once approved, new healthcare infrastructures and services, including primary healthcare, will be necessary to accommodate a huge demand for early and large-scale detection of AD. The increasing global accessibility of digital consumer electronics has opened up new prospects for early diagnosis and management of mild cognitive impairment (MCI) with particular regard to AD. This new wave of innovation has spurred research in both academia and industry, aimed at developing and validating a new "digital generation" of tools for the assessment of the cognitive performance. In light of this paradigm shift, an international working group (the Global Advisory Group on Future MCI Care Pathways) convened to elaborate on how digital tools may be optimally integrated in screening-diagnostic pathways of AD The working group developed consensus perspectives on new algorithms for large-scale screening, detection, and diagnosis of individuals with MCI within primary medical care delivery. In addition, the expert panel addressed operational aspects concerning the implementation of unsupervised at-home testing of cognitive performance. The ultimate intent of the working group's consensus perspectives is to provide guidance to developers of cognitive tests and tools to facilitate the transition toward globally accessible cognitive screening aimed at the early detection, diagnosis, and management of MCI due to AD.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Prev Alzheimers Dis

DOI

EISSN

2426-0266

Publication Date

2020

Volume

7

Issue

3

Start / End Page

158 / 164

Location

Switzerland

Related Subject Headings

  • Primary Health Care
  • Practice Guidelines as Topic
  • Mental Status and Dementia Tests
  • Mass Screening
  • Humans
  • Early Diagnosis
  • Digital Technology
  • Consensus
  • Cognitive Dysfunction
  • Alzheimer Disease
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sabbagh, M. N., Boada, M., Borson, S., Chilukuri, M., Doraiswamy, P. M., Dubois, B., … Hampel, H. (2020). Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) Supported by Emerging Digital Technologies. J Prev Alzheimers Dis, 7(3), 158–164. https://doi.org/10.14283/jpad.2020.19
Sabbagh, M. N., M. Boada, S. Borson, M. Chilukuri, P. M. Doraiswamy, B. Dubois, J. Ingram, et al. “Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) Supported by Emerging Digital Technologies.J Prev Alzheimers Dis 7, no. 3 (2020): 158–64. https://doi.org/10.14283/jpad.2020.19.
Sabbagh MN, Boada M, Borson S, Chilukuri M, Doraiswamy PM, Dubois B, et al. Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) Supported by Emerging Digital Technologies. J Prev Alzheimers Dis. 2020;7(3):158–64.
Sabbagh, M. N., et al. “Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) Supported by Emerging Digital Technologies.J Prev Alzheimers Dis, vol. 7, no. 3, 2020, pp. 158–64. Pubmed, doi:10.14283/jpad.2020.19.
Sabbagh MN, Boada M, Borson S, Chilukuri M, Doraiswamy PM, Dubois B, Ingram J, Iwata A, Porsteinsson AP, Possin KL, Rabinovici GD, Vellas B, Chao S, Vergallo A, Hampel H. Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) Supported by Emerging Digital Technologies. J Prev Alzheimers Dis. 2020;7(3):158–164.

Published In

J Prev Alzheimers Dis

DOI

EISSN

2426-0266

Publication Date

2020

Volume

7

Issue

3

Start / End Page

158 / 164

Location

Switzerland

Related Subject Headings

  • Primary Health Care
  • Practice Guidelines as Topic
  • Mental Status and Dementia Tests
  • Mass Screening
  • Humans
  • Early Diagnosis
  • Digital Technology
  • Consensus
  • Cognitive Dysfunction
  • Alzheimer Disease